VantAI platform Revenue and Competitors

Location

#6731

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • VantAI platform's estimated annual revenue is currently $11M per year.(i)
  • VantAI platform's estimated revenue per employee is $169,308

Employee Data

  • VantAI platform has 65 Employees.(i)
  • VantAI platform grew their employee count by 7% last year.

VantAI platform's People

NameTitleEmail/Phone
1
Founder & CEOReveal Email/Phone
2
Co-Founder & CTOReveal Email/Phone
3
COO and CFOReveal Email/Phone
4
Head Application EngineeringReveal Email/Phone
5
SVP, Head Drug DiscoveryReveal Email/Phone
6
Head PeopleReveal Email/Phone
7
Head PeopleReveal Email/Phone
8
Associate Director R&D Strategy and OperationsReveal Email/Phone
9
Associate Director R&D OperationsReveal Email/Phone
10
Senior Director ControllerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M30%N/AN/A
#2
N/A2043%N/AN/A
#3
$6.7M33-6%N/AN/A
#4
$34.4M222-1%N/AN/A
#5
$5.2M670%$10MN/A
#6
$2M130%N/AN/A
#7
$7.5M370%$51.6MN/A
#8
$0.3M1-50%N/AN/A
#9
$4.3M21-16%$3.3MN/A
#10
$3.6M205%N/AN/A
Add Company

What Is VantAI platform?

VantAI pairs bleeding-edge machine learning techniques with deep systems biology expertise to build computational models that uncover hidden relationships between molecules, targets, and diseases. These models power a best-in-class solution that identifies and generates new molecular entities for targets of interest, repurposes existing molecules at any stage of development, uncovers accurate ADME and toxicological insights, and predicts adverse events likely to influence trial success from deep analysis of systems-based pharmacogenomics. VantAI's in silico platform specializes in modelling complex protein-protein interactions, powering the discovery of biologics and protein degraders in addition to small-molecule drugs. It has helped leading biopharma partners launch new development programs--or revitalize old ones--at a fraction of the time and cost of traditional methods. For more information, please visit http://www.vant.ai.

keywords:N/A

N/A

Total Funding

65

Number of Employees

$11M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

VantAI platform News

2022-04-17 - VantAI Forms Research Collaboration with Boehringer ...

VantAI will pair its induced proximity platform with BI's deep early discovery experience to identify targeted protein degraders with...

2022-04-17 - VantAI Inks Second Big Protein Degrader Collab in as Many ...

They will use VantAI's geometric deep learning platform to “computationally streamline the design of new molecules optimized for each E3...

2022-04-13 - VantAI Announces Multi-Year Protein Degrader Discovery ...

NEW YORK, April 13, 2022 (GLOBE NEWSWIRE) -- VantAI, an AI-first ... and Janssen will leverage VantAI's geometric deep learning platform to...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.1M6523%$44.4M
#2
$14.3M650%N/A
#3
$7.9M65-7%$28.1M
#4
$12.9M655%N/A
#5
$12.9M6510%N/A